Tango Therapeutics Inc
NASDAQ:TNGX
Tango Therapeutics Inc
NASDAQ:TNGX
Price:
11.11
USD
-2.54%
Market Closed
Market Cap:
$1.5B
Cash Flow Statement
Cash Flow Statement
Tango Therapeutics Inc
Tango Therapeutics Inc
Currency: USD
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(0)
|
(1)
|
(36)
|
(58)
|
(83)
|
(107)
|
(101)
|
(108)
|
(111)
|
(107)
|
(100)
|
(102)
|
(112)
|
(116)
|
(123)
|
(130)
|
(132)
|
(146)
|
(101)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
3
|
4
|
7
|
8
|
10
|
12
|
13
|
14
|
15
|
17
|
18
|
19
|
22
|
24
|
26
|
29
|
29
|
28
|
28
|
|
| Other Non-Cash Items |
(0)
|
(0)
|
6
|
9
|
13
|
17
|
14
|
16
|
17
|
18
|
20
|
19
|
21
|
24
|
24
|
28
|
29
|
28
|
29
|
|
| Change in Working Capital |
0
|
0
|
(14)
|
(11)
|
(20)
|
(31)
|
(12)
|
(18)
|
(22)
|
(21)
|
(41)
|
(38)
|
(33)
|
(30)
|
(25)
|
(32)
|
(35)
|
(34)
|
(77)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(1)
-179%
|
(43)
-3 833%
|
(60)
-39%
|
(89)
-50%
|
(120)
-35%
|
(98)
+19%
|
(109)
-12%
|
(114)
-5%
|
(107)
+6%
|
(119)
-11%
|
(118)
+1%
|
(121)
-3%
|
(120)
+1%
|
(122)
-2%
|
(132)
-8%
|
(135)
-3%
|
(149)
-10%
|
(146)
+2%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
(1)
|
(2)
|
(3)
|
(5)
|
(7)
|
(8)
|
(7)
|
(6)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
0
|
(167)
|
(137)
|
(182)
|
(192)
|
(154)
|
1
|
34
|
76
|
72
|
(3)
|
43
|
(0)
|
(21)
|
69
|
87
|
129
|
133
|
148
|
|
| Cash from Investing Activities |
0
N/A
|
(167)
N/A
|
(138)
+17%
|
(183)
-33%
|
(195)
-6%
|
(160)
+18%
|
(6)
+96%
|
26
N/A
|
70
+164%
|
67
-4%
|
(5)
N/A
|
41
N/A
|
(1)
N/A
|
(21)
-1 796%
|
68
N/A
|
86
+27%
|
128
+48%
|
132
+3%
|
147
+11%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
172
|
31
|
31
|
31
|
32
|
1
|
2
|
1
|
1
|
82
|
82
|
125
|
125
|
48
|
48
|
5
|
4
|
4
|
|
| Other |
0
|
0
|
327
|
326
|
326
|
326
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
168
N/A
|
357
+112%
|
357
0%
|
358
+0%
|
358
+0%
|
1
-100%
|
2
+67%
|
1
-12%
|
1
-9%
|
81
+6 167%
|
82
+1%
|
125
+52%
|
126
+0%
|
48
-62%
|
48
-1%
|
5
-90%
|
4
-9%
|
4
-4%
|
|
| Change in Cash | ||||||||||||||||||||
| Net Change in Cash |
1
N/A
|
1
-56%
|
176
+31 964%
|
114
-35%
|
73
-36%
|
79
+7%
|
(103)
N/A
|
(81)
+21%
|
(43)
+47%
|
(39)
+10%
|
(42)
-8%
|
6
N/A
|
3
-46%
|
(15)
N/A
|
(6)
+59%
|
2
N/A
|
(3)
N/A
|
(12)
-344%
|
5
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(1)
-179%
|
(44)
-3 938%
|
(61)
-39%
|
(93)
-51%
|
(125)
-35%
|
(105)
+16%
|
(117)
-11%
|
(121)
-4%
|
(113)
+7%
|
(121)
-7%
|
(120)
+1%
|
(122)
-2%
|
(120)
+1%
|
(123)
-2%
|
(132)
-7%
|
(136)
-3%
|
(150)
-10%
|
(147)
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
